Chicago Atlantic Q2 distributable earnings $0.55/share; net interest income $13.7M; NY fund $150M

Chicago Atlantic Real Estate Finance, Inc.

2023-Q2 EPS reported $1.07 revenue$28,573,304

Net interest income $13.7M (down 8.3% sequentially); provision for credit losses $5.2M (up $1.1M).
Distributable earnings $10.1M or $0.55 per diluted share; book value $15.06 (from $15.04).
Leverage 16%; liquidity $46.4M ($4.4M cash + $42M credit facility availability).
New York Cannabis Social Equity Investment Fund: up to $150M; $18.8M advanced for 17 dispensaries.
Quarterly dividend $0.47 per share paid July 14; 2023 outlook affirmed.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Chicago Atlantic Real Estate Finance, Inc. reported second quarter ended June 30, 2023 results: revenue approximately $13.7 million, net income approximately $10.1 million, EPS $0.55 per weighted average diluted common share. Guidance reaffirmed.

Period: second quarter ended June 30, 2023
Revenue: approximately $13.7 million
Net income: approximately $10.1 million
EPS: $0.55 per weighted average diluted common share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

of common stock for the second quarter of 2023 to common stockholders of record on June 30, 2023. Second Quarter 2023 Financial Results ● Net interest income of approximately $13.7 million, representing a sequential decrease of 8.3%; due to the impact of timing of early principal repayments and lower average principal outstanding during the three months ended

View on SEC.gov

Browse all earnings releases →

Chicago Atlantic Real Estate Finance, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-064754

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.